An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But regulatory approval and new data are signaling the tide may be turning
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But regulatory approval and new data are signaling the tide may be turning